Mon 30 Nov 2009 | 23:55 EST

You are here: Home > News > Article

Do More With Reuters

Partner Services

Affiliate Network

Professional Products

Support (Customer Zone)

Financial Products

About Thomson Reuters

Teva Pharm announces approval of Terbinafine HCL tablets

Tue Jul 3, 2007 8:39am EDT

Email | Print |

Share

| Reprints | Single Page

[-] Text [+]

Co announces that the FDA has granted final approval for the co's Abbreviated New Drug Application to market Terbinafine Hydrochloride Tablets, 250 mg, the AB-rated generic equivalent of Novartis' antifungal agent Lamisil Tablets. Shipment of this product will begin immediately.

© Thomson Reuters 2009 All rights reserved

Share:

Also On Reuters

Blog: Why is Starbucks hiding its iconic logo?

A street lamp is seen in front of the Datong second coal-fired power plant at night on the outskirts of Datong, Shanxi province, November 20,2009. REUTERS/Jason Lee

Big developing countries form climate change front

Oprah Winfrey arrives at the "Precious" film screening during the 34th Toronto International Film Festival, September 13, 2009. REUTERS/Mark Blinch

Reuters Media Summit: Life after Oprah

More InPlay Briefing.com

Insight Enterprises' board authorizes additional $50 mln stock repurchase

Ampex and Hillside agree to 60 day extension to standstillaAgreement; engages Commercial Strategy to pursue licensing efforts

New Oriental reports Q2 EPS of $0.07 vs $0.10 in 2Q07; revs rose 129% to $18.2 mln - no ests

General Steel reports Q3 EPS of $0.25 vs $0.20 two analyst est; revs rose $636% YoY to $345.4 mln vs $289.86 mln two analyst est

Ansoft beats by $0.01, reports revs in-line

More InPlay Briefing.com News...

Featured Broker sponsored link

Editor's Choice

The Amazon forest burns next to the city of Mandaquiri

A selection of our best photos from the past 24 hours. Slideshow

Most Popular on Reuters

Articles
Video

Most Popular Articles RSS Feed

Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS | Labs | Journalism Handbook | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.